| ZULVIDA Incyte Holdings Corporation
2047989 20 May 2020 | on 31 Dec 1969 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment and prevention of cancer, oncological disorders, autoimmune disorders, inflammation and inflammatory disorders, hematological disorders, respiratory and infectious diseases, tissue and organ transplant rejection, dermatological disorders, connective tissue disorders, musculo-skeletal disorders, and ophthalmology disorders. Class 044 Class 044 Medical, Beauty & Agricultural Services Providing patients and healthcare professionals with healthcare information regarding diseases, diagnosis and treatment of diseases, medicines, via a website. | | | ZUKODA GLAXO GROUP LIMITED
1704182 24 Nov 2014 | on 10 Oct 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of atherosclerosis; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; Pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; Pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; Pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; Pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; Pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of muscular dystrophy Class 044 Class 044 Medical, Beauty & Agricultural Services Cell and gene therapy services | | | ZURICH NORTH AMERICA CANADA ZURICH INSURANCE COMPANY LTD (TRANSLATIONS: ZÜRICH VERSICHERUNGS-GESELLSCHAFT AG; ZURICH COMPAGNIE D'ASSURANCES SA; ZURIGO COMPAGNIA DI ASSICURAZIONI SA; ZURICH COMPAÑIA DE SEGUROS SA)
1112296 09 Aug 2001 | on 31 Dec 1969 | Class 028 Class 028 Toys and Sporting Goods Products Stuffed dolls. Class 035 Class 035 Advertising, Business & Retail Services Insurance services and financial services, namely financial management services, financial planning services, asset management services, the provision of mutual funds and segregated funds and investment services namely, mutual fund investment services, investment brokerage services, investment management services and investment of funds for others; underwriting service and warranty contracts, and issuing service and warranty contracts. Class 036 Insurance & Financial Services Business administration.
Class 042 Computer & Software Services & Scientific Services Providing of food and drink; temporary accommodation; legal services; computer programming.
Class 043 Restaurant and Hotel Services
Class 045 Personal & Legal & Social Services | | | ZURICH CANADA ZURICH INSURANCE COMPANY LTD (translations: Zürich Versicherungs-Gesellschaft AG; Zurich Compagnie d'Assurances SA; Zurigo Compagnia di Assicurazioni SA; Zurich Compañia de Seguros SA)
666389 10 Sep 1990 | on 13 Sep 1996 | Class 036 Class 036 Insurance & Financial Services All apsects of insurance connected with insurance services. | | | ZUBELDA IMPERIAL TOBACCO PRODUCTS LIMITED
990435 31 Dec 1969 | on 21 Dec 1912 | Class 034 Class 034 Smoker's Products TOBACCO | |